One Step Membrane Incorporation of Viral Antigens as a Vaccine Candidate Against HIV

References

• Abraham E., Shah S. Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. J. Immunol. 1992; 149: 3719–3726
   PubMed Web of Science ®Google Scholar
• Allison A. C. Adjuvants and immune enhancement. Int. J. Technol. Assess. Health Care 1994; 10(1)107–120
   PubMedGoogle Scholar
• Alving C. R. Liposomes as carriers of antigens and adjuvants. J. Immunol. Methods 1991; 140: 1–13
   PubMed Web of Science ®Google Scholar
• Amorena B., Baselga R., Albizu I. Use of liposome-immunopotentiated exopolysaccharide as a component of an ovine mastitis staphylococcal vaccine. Vaccine 1994; 12: 243–249
   PubMed Web of Science ®Google Scholar
• Anholt R. R. H. Functional reconstitution of the olfactory membrane: incorporation of the olfactory adenylate cyclase in liposomes. Biochemistry 1988; 27: 6464–6468
   PubMed Web of Science ®Google Scholar
• Anholt R. R. H., Aebi U., Pedersen P. L., Snyder S. H. Solubilization and reassembly of the mitochondrial benzodiazepine receptor. Biochemistry 1986; 25: 2120–2125
   PubMed Web of Science ®Google Scholar
• Antimisiaris S. G., Jayasekera P., Gregoriadis G. Liposomes as vaccine carriers Incorporation of soluble and particulate antigens in giant vesicles. J. Immunol. Methods 1993; 166: 271–280
   PubMed Web of Science ®Google Scholar
• Bangham A. D., Standish M. M., Watkins J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 1965; 13: 238–252
   PubMed Web of Science ®Google Scholar
• Barenholz Y., Amselem S., Lichtenberg D. A new method for preparation of phospholipid vesicles (liposomes)-french press. FEBS Lett. 1979; 99: 210–214
   PubMed Web of Science ®Google Scholar
• Batzri S., Korn E. D. Single bilayer liposomes prepared without sonication. Biochim. Biophys. Acta 1973; 298: 1015–1019
   PubMed Web of Science ®Google Scholar
• Brandl M., Bachmann D., Drechsler M., Bauer K. H. Liposome preparation by a new high pressure homogenizer Gaulin Micron LAB 40. Drug Dev. Ind. Pharm. 1990; 16: 2167–2191
   Web of Science ®Google Scholar
• Brunner J., Skrabal P., Hauser H. Single bilayer vesicles prepared without sonication. Biochim. Biophys. Acta 1976; 455: 322–331
   PubMed Web of Science ®Google Scholar
• Buiting A. M. J., Van Rooijen N., Claassen E. 44th Forum in Immunology. 1992; 541–548
   Google Scholar
• Bülow R., Boothroyd J. C. Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. J. Immunol. 1991; 147: 3496–3500
   PubMed Web of Science ®Google Scholar
• Cohen S., Alonso M. J., Langer R. Novel approaches to controlled-release antigen delivery. Int. J. Technol. Assess. Health Care 1994; 10(1)121–130
   PubMedGoogle Scholar
• Deamer D., Bangham A. D. Large volume liposomes by an ether vaporization method. Biochim. Biophys. Acta 1976; 443: 629–634
   PubMed Web of Science ®Google Scholar
• DeGrip W. J., Vanoostrum J., Bovee-Geurts P. H. Selective detergent-extraction from mixed detergent/lipid/protein micelles, using cyclodextrin inclusion compounds: a novel generic approach for the preparation of proteoliposomes. Biochem. J. 1998; 330: 667–674
   PubMed Web of Science ®Google Scholar
• Driessen A. J. M., Wickner W. Solubilization and functional reconstitution of the protein-translocation enzymes of Escherichia coli. Proc. Natl. Acad. Sci. USA 1990; 87: 3107–3111
   PubMed Web of Science ®Google Scholar
• Garcon N. M. J., Six H. R. Universal vaccine carrier: Liposomes that provide T-dependent help to weak antigens. J. Immunol. 1991; 146: 3697–3702
   PubMed Web of Science ®Google Scholar
• Glück R. Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens. Vaccine 1992; 10: 915–919
   PubMed Web of Science ®Google Scholar
• Glück R., Mischler R., Brantschen S., Just M., Althaus B., Cryz S. J. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis. A. J. Clin. Invest. 1992; 90: 2491–2495
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunol. Today 1990; 11: 89–97
   PubMedGoogle Scholar
• Grundner C., Mirzabekov T., Sodroski J., Wyatt R. Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins. J Virol. 2002; 76(7)3511–3521
   PubMed Web of Science ®Google Scholar
• Gupta R. K., Relyveld E. H., Lindblad E. B., Bizzini B., Ben-Efrain S., Gupta C. K. Adjuvants—a balance between toxicity and adjuvanticity. Vaccine 1993; 11: 293–306
   PubMed Web of Science ®Google Scholar
• Huang C. Studies on phosphatidycholine vesicles. Formation and physical characterization. Biochemistry 1969; 8: 344–351
   PubMed Web of Science ®Google Scholar
• Hui G. S. N. Liposomes, muramyl dipeptide derivatives, and nontoxic lipid a derivatives as adjuvants for human malaria vaccines. Am. J. Trop. Med. Hyg. 1994; 50: 41–51
   PubMed Web of Science ®Google Scholar
• Jackson M. L., Litman B. J. Rhodopsin-phospholipid reconstitution by dialysis removal of octyl glucoside. Biochemistry 1982; 21: 5601–5608
   PubMed Web of Science ®Google Scholar
• Jagodzinski L. L., Ammann C., Jager W., Jacobson J., Vetter N., Katinger H. Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation. AIDS 2002., 16(15)2019–25
   Google Scholar
• Just M., Berger R., Drechsler H., Brantschen S., Glück R. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks. Vaccine 1992; 10: 737–739
   PubMed Web of Science ®Google Scholar
• Lambert O., Lévy D., Ranck J. L., Leblanc G., Rigaud J. L. A new gel-like phase in dodecyl maltoside–lipid mixtures: Implications in solubilization and reconstitution studies. Biophys. J. 1998; 74: 918–930
   PubMed Web of Science ®Google Scholar
• Lenz O., Dittmar M. T., Wagner A., Ferko B., Vorauer-Uhl K., Stiegler G., Weissenhorn W. Trimeric membrane-anchored gp41 inhibits HIV membrane fusion. J Biol Chem. 2005; 280(6)4095–101
   PubMed Web of Science ®Google Scholar
• Liu J., Rutz J. M., Feix J. B., Klebba P. E. Permeability properties of a large gated channel within the ferric enterobactin receptor, FepA. Proc. Natl. Acad. Sci. USA 1993; 90: 10653–10657
   PubMed Web of Science ®Google Scholar
• Mayhew E., Lazo R., Vail W. J., King J., Green A. M. Characterization of liposomes prepared using a microemulsifier. Biochim. Biophys. Acta 1984; 775: 169–174
   PubMed Web of Science ®Google Scholar
• Milsman M. H. W., Schwendener R. A., Weder H. G. The preparation of large single bilayer liposomes by a fast and controlled dialysis. Biochim. Biophys. Acta 1978; 512: 147–155
   PubMed Web of Science ®Google Scholar
• Muttilainen S., Idänpään-Heikkilä I., Wahlström E., Nurminen M., Mäkelä P. H., Sarvas M. The Neisseria meningitides outer membrane protein P1 produced in Bacillus subtilisand reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes. Microb. Pathog. 1995; 18: 423–436
   PubMed Web of Science ®Google Scholar
• Olson F., Hunt C. A., Szoka F. C., Vail W. J., Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta 1979; 557: 9–23
   PubMed Web of Science ®Google Scholar
• Purtscher M., Trkola A., Gruber G., et al. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retrovir. 1994; 10(12)1651–1658
   PubMed Web of Science ®Google Scholar
• Reed L. J., Muench H. Am. J. Hygiene 1938; 27: 493–497
   Google Scholar
• Rhoden V., Goldin S. M. Formation of unilamellar lipid vesicles of controllable dimensions by detergent dialysis. Biochemistry 1979; 18: 4173–4176
   PubMed Web of Science ®Google Scholar
• Schurtenberger P., Mazer N., Waldvogel S., Känzig W. Preparation of monodisperse vesicles with variable size by dilution of mixed micellar solutions of bile salt and phosphatidylcholine. Biochim. Biophys. Acta 1984; 775: 111–114
   PubMed Web of Science ®Google Scholar
• Stahn R., Schäfer H., Kunze M., Malur J., Ladhoff A., Lachmann U. Quantitative reconstitution of isolated influenza haemagglutinin into liposomes by the detergent method and the immunogenicity of haemagglutinin liposomes. Acta Virol. 1992; 36: 129–144
   PubMed Web of Science ®Google Scholar
• Stiegler G., Armbruster C., Vcelar B., Stoiber H., Kunert R., Michael N. L., Stiegler G., Kunert R., Purtscher M., Wolbank S., Voglauer R., Steindl F., Katinger H. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 2001; 17(18)1757–1765
   PubMed Web of Science ®Google Scholar
• Szoka F., Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA 1978; 75: 4194–4198
   PubMed Web of Science ®Google Scholar
• Thérien H.-M., Lair D., Shahum E. Liposomal vaccine: Influence of antigen association on the kinetics of the humoral response. Vaccine 1990; 8: 558–562
   PubMed Web of Science ®Google Scholar
• Tranum-Jensen J., Christiansen K., Carlsen J., Brenzel G., Vinten J. Membrane topology of insulin receptors reconstituted into lipid vesicles. J. Membr. Biol. 1994; 140: 215–223
   PubMed Web of Science ®Google Scholar
• Trkola A., Purtscher M., Muster T., et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virology 1996; 70: 1100–1108
   PubMed Web of Science ®Google Scholar
• Wagner A., Vorauer-Uhl K., Katinger H. Liposome produced in a pilot scale: production, purification and efficiency aspects. Eur J Pharm Biopharm 2002; 54: 213–219
   PubMed Web of Science ®Google Scholar
• Wagner A., Vorauer-Uhl K., Kreismayr G., Katinger H. The crossflow injection technique—an improvement of the ethanol injection method. Journal of Liposome Research 2002; 12(3)259–270
   PubMed Web of Science ®Google Scholar
• Wagner A., Vorauer-Uhl K., Kreismayr G., Katinger H. Enhanced protein loading into liposomes by the multiple injection technique. Journal of Liposome Research 2002; 12(3)271–283
   PubMed Web of Science ®Google Scholar
• White K., Krzych U., Gordon D. M., et al. Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes. Vaccine 1993; 11: 1341–1346
   PubMed Web of Science ®Google Scholar